TrialPloS one2017

Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3.

Judith S Currier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.